Your browser doesn't support javascript.
loading
Distribution of residual tumors in esophageal squamous cell carcinoma after neoadjuvant PD-1 blockade combined with chemotherapy.
Jiang, Dongxian; Song, Qi; Tang, Han; Shi, Peng; Zhang, Xiaolei; Liu, Yufeng; Wang, Haixing; Deng, Minying; Huang, Jie; Su, Jieakesu; Xu, Chen; Tan, Lijie; Hou, Yingyong.
Afiliación
  • Jiang D; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Song Q; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
  • Tang H; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shi P; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhang X; Center for Evidence-based Medicine, Fudan University, Shanghai, China.
  • Liu Y; Pediatric Clinical Research Unit, Department of Research Management, Children's Hospital of Fudan University, Shanghai, China.
  • Wang H; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Deng M; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Huang J; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Su J; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Xu C; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Tan L; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Hou Y; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Front Oncol ; 13: 1067897, 2023.
Article en En | MEDLINE | ID: mdl-36925921

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: China